| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology, Universities of Würzburg (Drs. Schneider, Ricker, Reiners, and Toyka) and Heidelberg (Dr. Meinck), the Institute of Medical Biometry and Epidemiology, University of Marburg (Dr. Ziegler), the Department of Human Genetics, University of Würzburg (Drs. Grimm and Kress), and the Division of Clinical Neurophysiology, University of Göttingen (Dr. Reimers), Germany.
Address correspondence and reprint requests to Dr. Christiane Schneider or Dr. Kenneth Ricker, Neurologische Klinik der Julius-Maximilians-Universität Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany; e-mail: chris.schneider{at}mail.uni-wuerzburg.de
OBJECTIVE: To investigate anticipation in proximal myotonic myopathy (PROMM).
BACKGROUND: PROMM is a recently described autosomal dominantly inherited disorder similar to but distinct from myotonic dystrophy (DM). DM belongs to the group of inherited disorders with anticipation caused by an unstable trinucleotide repeat expansion. In PROMM, no mutation has been identified, although PROMM has recently been mapped to a gene locus on chromosome 3q.
METHODS: We investigated 10 German families with the PROMM phenotype and linkage to chromosome 3q. We based our analysis of anticipation on the age of disease onset. Anticipation was assumed if the offspring had first symptoms earlier in life than his or her affected parent. For statistical analysis Independence Estimating Equations (IEE) and a Monte-Carlo bootstrap were used.
RESULTS: In 27 affected living parent-offspring pairs from these 10 families, the mean difference of disease onset was 18.8 years with either statistical analysis (p < 10-14 and p < 10-15). The mean disease onset interval in years was greater in father-offspring as compared to the mother-offspring pairs (p < 0.05; IEE).
CONCLUSION: Our findings suggest the occurrence of anticipation in parent-offspring pairs from families with the PROMM phenotype and linkage to chromosome 3q. The different disease onset intervals in mother-offspring and father-offspring pairs could indicate a mild parent-of-origin effect. These observations are compatible with the suggestion that PROMM, like DM, may be a trinucleotide repeat associated disorder. In contrast to DM, anticipation in PROMM is milder, a congenital form does not seem to occur, and fertility does not appear to be affected.
This article has been cited by other articles:
|
|
 |
|
  J. W. Day, K. Ricker, J. F. Jacobsen, L. J. Rasmussen, K. A. Dick, W. Kress, C. Schneider, M. C. Koch, G. J. Beilman, A. R. Harrison, et al. Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum Neurology, February 25, 2003; 60(4): 657 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fardaei, M. T. Rogers, H. M. Thorpe, K. Larkin, M. G. Hamshere, P. S. Harper, and J. D. Brook Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells Hum. Mol. Genet., April 1, 2002; 11(7): 805 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mankodi, C. R. Urbinati, Q.-P. Yuan, R. T Moxley, V. Sansone, M. Krym, D. Henderson, M. Schalling, M. S. Swanson, and C. A. Thornton Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2 Hum. Mol. Genet., September 1, 2001; 10(19): 2165 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Liquori, K. Ricker, M. L. Moseley, J. F. Jacobsen, W. Kress, S. L. Naylor, J. W. Day, and L. P. W. Ranum Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 Science, August 3, 2001; 293(5531): 864 - 867. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
